Table 3.
Cancer Sites Represented in the 171 Retained Studies
| Cancer Site | Number of studies (%) |
|---|---|
| Breast | 51 (29.8) |
| Breast and gynecologic | 4 (2.3) |
| Two or more gynecologic sites | 23 (13.5) |
| Ovarian | 5 (2.9) |
| Endometrial | 9 (5.3) |
| Vaginal | 1 (0.6) |
| Vulvar | 5 (2.9) |
| Cervical | 22 (12.9) |
| Colorectal | 14 (8.2) |
| Colon | 1 (0.6) |
| Rectal | 14 (8.2) |
| Anal | 3 (1.8) |
| Rectal and anal | 1(0.6) |
| Bladder | 2 (1.2) |
| Hodgkin’s Disease | 1(0.6) |
| Non-Hodgkin’s lymphoma | 1(0.6) |
| Bone | 1(0.6) |
| Head and neck | 2 (1.2) |
| Melanoma | 1(0.6) |
| Multiple adult sites | 8 (4.7) |
| Childhood cancer sites | 2 (1.2) |